![Li Chen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Li Chen
Private Equity Investor bij
Agave Partners
Profiel
Li Chen is currently a Managing Director at Agave Partners since 2015.
Prior to this, she worked as a Director at Abbott Laboratories from 2012 to 2015.
Dr. Chen received a graduate degree from the University of Connecticut in 1993 and a doctorate degree from Tsinghua University in 1989.
Actieve functies van Li Chen
| Bedrijven | Functie | Begin |
|---|---|---|
Agave Partners
 Agave Partners Investment ManagersFinance Agave Partners invests in companies located in the United States with maximum revenues of USD 50 million. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. It also takes board seat. | Private Equity Investor | 01-01-2015 |
Eerdere bekende functies van Li Chen
| Bedrijven | Functie | Einde |
|---|---|---|
| ABBOTT LABORATORIES | Directeur/Bestuurslid | 31-10-2015 |
Opleiding van Li Chen
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
93
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
University of Connecticut
 University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tsinghua University
 Tsinghua University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Agave Partners
Agave Partners Investment ManagersFinance Agave Partners invests in companies located in the United States with maximum revenues of USD 50 million. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. It also takes board seat. | Finance |
Kies MarketScreener 
